Follow The Filings

RKLB Rocket Lab

Rocket Lab earnings company data as of 4:07 PM ET 10/30

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —
FY2026 Q2 10 Aug EPS -0.08 -0.08 Miss
Rev $230.9M $234.0M Beat +1.3%

Insider trades

Open-market buys and sales by RKLB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RKLB insider trades
  • None no insider bought on the open market
  • $41.5M sold by 6 insiders outside a trading plan
  • $598M sold by 7 insiders under 10b5-1 plans
  1. Adam C. Spice CFO
    Planned sale
    $9.9M 140,157 shares at $70.82 11% of stake
    Traded Oct 1 Filed Oct 2
  2. Adam C. Spice CFO
    Planned sale
    $8.8M 140,157 shares at $62.63 11% of stake
    Traded Sep 2 Filed Sep 4
  3. Frank Klein Chief Operations Officer
    Planned sale
    $2.4M 35,558 shares at $66.61 3.7% of stake
    Traded Aug 27 Filed Aug 28
  4. Arjun Kampani SVP & General Counsel
    Planned sale
    $402K 6,034 shares at $66.65 2.3% of stake
    Traded Aug 27 Filed Aug 28
  5. Peter Beck CEO
    Planned sale
    $286M 3,275,779 shares at $87.43 66% of stake
    Traded Jul 6–8 Filed Jul 8
  6. Arjun Kampani SVP & General Counsel
    Sale
    $9.5M 88,000 shares at $107.98 25% of stake
    Traded Jun 18 Filed Jun 18
  7. Alexander R Slusky Director
    Sale
    $4.9M 40,000 shares at $123.60 11% of stake
    Traded Jun 2 Filed Jun 5
  8. Alexander R Slusky Director
    Sale
    $9M 60,000 shares at $149.40 14% of stake
    Traded May 28 Filed Jun 1
  9. Frank Klein Chief Operations Officer
    Planned sale
    $5.4M 36,860 shares at $147.42 3.5% of stake
    Traded May 28 Filed Jun 1
  10. Marvin Bradford Clevenger President, Rocket Lab USA, Inc
    Sale
    $513K 3,500 shares at $146.67 0.7% of stake
    Traded May 28 Filed Jun 1
  11. Arjun Kampani SVP & General Counsel
    Planned sale
    $3.5M 23,804 shares at $147.43 6.3% of stake
    Traded May 28 Filed Jun 1
  12. Arjun Kampani SVP & General Counsel
    Planned sale
    $10.2M 70,000 shares at $145.13 16% of stake
    Traded May 27 Filed May 28
  13. Alexander R Slusky Director
    Sale
    $11.8M 100,000 shares at $118.08 19% of stake
    Traded May 12 Filed May 14
  14. Merline Saintil Director
    Sale
    $1.4M 18,126 shares at $75.04 6.5% of stake
    Traded Mar 6 Filed Mar 9
  15. Frank Klein Chief Operations Officer
    Planned sale
    $2.6M 36,768 shares at $71.95 3.3% of stake
    Traded Mar 4 Filed Mar 4

Also filed in the last 12 months, not counted as buying or selling: 71 sales to cover taxes, 13 gifts, 10 stock grants, 3 option exercises, and 1 conversion.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01
8-K 7.01,8.01,9.01
424B3
8-K 8.01,9.01
424B5
8-K 7.01,8.01,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
8-K 1.01,7.01,9.01
8-K 5.02

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.